Department of Thoracic Surgery, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
Thorac Cancer. 2020 Jul;11(7):1840-1847. doi: 10.1111/1759-7714.13464. Epub 2020 May 8.
To evaluate the oncological prognosis and neurological outcomes for patients with thymic epithelial tumors (TETs) after thymectomy.
Consecutive patients with TETs who underwent thymectomy at Beijing Hospital from January 2011 to December 2018 were retrospectively enrolled into the study. Clinical, pathological, and perioperative data was collected. Patients were followed-up by telephone interview and outpatient records. Statistical analyses were performed using SPSS version 19.0.
A total of 215 patients (115 men and 100 women) were included in this study of which 133 patients (61.9%) had TETs associated with myasthenia gravis (MG), and 82 patients (38.1%) had thymic tumors without MG. A total of 194 (90.2%) patients were successfully followed-up. The median follow-up period was 42 months. The five-year overall survival (OS) rate was 88.6%. MG was the first cause of death for patients with MG (6/10). Prognosis in MG patients was similar to those without MG. Multivariate Cox regression analysis demonstrated that TNM stage III + IV was an independent risk factor for OS. Incomplete resection and younger age were risk factors for tumor recurrence. For patients with MG, the cumulative complete stable remission (CSR) rate increased with the postoperative follow-up period, and the five-year CSR rate was 44.7%. Univariate Cox analysis indicated that age, preoperative MG duration and preoperative medication might correlate with CSR. Multivariate Cox analysis only indicated older age as a negative factor of achieving CSR.
MG had little influence on OS and tumor recurrence of thymic tumors. The new TNM staging system was an independent prognostic factor. Incomplete resection and younger age were risk factors for tumor recurrence. Older age was a negative factor of achieving CSR for thymoma patients with MG after extended thymectomy.
Significant findings of the study MG was not a prognostic factor for thymic tumors. The new TNM staging system was useful for prediction of prognosis. Incomplete resection and younger age were risk factors for tumor recurrence. Older age led to a lower probability of achieving CSR for thymomatous MG. What this study adds This study had a relatively large sample size of patients with thymic epithelial tumors in a single center. We evaluated not only the oncological prognosis, but also neurological outcomes after thymectomy, which was a more comprehensive assessment of surgical effect for thymic epithelial tumors.
评估胸腺上皮肿瘤(TETs)患者胸腺切除术后的肿瘤学预后和神经学结局。
回顾性纳入 2011 年 1 月至 2018 年 12 月在北京医院行胸腺切除术的 TETs 患者,收集临床、病理和围手术期数据。通过电话访谈和门诊记录对患者进行随访。采用 SPSS 19.0 版进行统计学分析。
本研究共纳入 215 例患者(男 115 例,女 100 例),其中 133 例(61.9%)患者 TETs 合并重症肌无力(MG),82 例(38.1%)患者胸腺肿瘤不合并 MG。194 例(90.2%)患者成功随访,中位随访时间为 42 个月。5 年总生存率(OS)为 88.6%。MG 是合并 MG 患者的首要死亡原因(6/10)。MG 患者的预后与不合并 MG 患者相似。多因素 Cox 回归分析表明,TNM 分期 III+IV 期是 OS 的独立危险因素。不完全切除和年龄较小是肿瘤复发的危险因素。对于合并 MG 的患者,术后随访期间累积完全稳定缓解(CSR)率增加,5 年 CSR 率为 44.7%。单因素 Cox 分析表明,年龄、术前 MG 病程和术前用药可能与 CSR 相关。多因素 Cox 分析仅表明年龄较大是 CSR 的负性因素。
MG 对胸腺肿瘤的 OS 和肿瘤复发影响较小。新的 TNM 分期系统是独立的预后因素。不完全切除和年龄较小是肿瘤复发的危险因素。年龄较大是影响合并 MG 的胸腺瘤患者术后获得 CSR 的负面因素。
本研究的重要发现 MG 不是胸腺瘤的预后因素。新的 TNM 分期系统有助于预测预后。不完全切除和年龄较小是肿瘤复发的危险因素。年龄较大导致胸腺瘤合并 MG 患者获得 CSR 的概率降低。本研究的新增内容本研究为单中心胸外科上皮性肿瘤患者,样本量较大。我们不仅评估了肿瘤学预后,还评估了胸腺切除术后的神经学结局,这是对胸外科上皮性肿瘤手术效果的更全面评估。